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Abstract
Background: Collybistin (CB), a neuron-specific guanine nucleotide exchange factor, has been implicated in
targeting gephyrin-GABAA receptors clusters to inhibitory postsynaptic sites. However, little is known about
additional CB partners and functions.
Findings: Here, we identified the p40 subunit of the eukaryotic translation initiation factor 3 (eIF3H) as a novel
binding partner of CB, documenting the interaction in yeast, non-neuronal cell lines, and the brain. In addition, we
demonstrated that gephyrin also interacts with eIF3H in non-neuronal cells and forms a complex with eIF3 in the
brain.
Conclusions: Together, our results suggest, for the first time, that CB and gephyrin associate with the translation
initiation machinery, and lend further support to the previous evidence that gephyrin may act as a regulator of
synaptic protein synthesis.
Findings
Gaining deeper insights into the roles of the molecular
players that mediate synapse formation and regulation is
crucial for understanding brain functions and human
disorders that affect learning and other cognitive skills,
such as autism spectrum disorders. Despite our expand-
ing knowledge in this area, the functions of several
synaptic proteins, mainly those regulating the develop-
ment and plasticity of inhibitory synapses, remain to be
explored further. One such synaptic component is
collybistin.
Collybistin (CB) is a brain-specific member of the
family of guanine nucleotide exchange factor (GEF) pro-
teins for small Rho-like GTPases [1]. Several CB splice
variants have been identified in rodent brain and spinal
cord [1,2]; all variants harbor the catalytic DH and
membrane-binding PH tandem domains, but differ by
the presence of an N-terminal SH3 domain, and by
alternative C-termini, which may contain a a-helical
coiled-coil motif. The human CB homologue (hPEM-2)
was shown to catalyze specific nucleotide exchange on
Cdc42 in fibroblasts and to activate actin polymerization
and changes in cell morphology [3].
CB binds to gephyrin [1], a major postsynaptic scaf-
folding protein required for the clustering of both gly-
cine and major classes of GABAA receptors [4-7].
Importantly, CB has been implicated in the translocation
of gephyrin from large cytoplasmic aggregates to the
plasma membrane of cultured cells, and the PH domain
of CB was shown to be required for this activity [8],
whereas the SH3 domain seems to negatively regulate
this activity [1,2]. Interestingly, it has recently been
shown that the SH3 domain of CB interacts with neuro-
ligin 2, a postsynaptic cell adhesion protein [9], and
with the GABAA receptor a2 subunit [10], and these
interactions seem to relieve the inhibitory effect of this
domain, thus rendering the CBSH3+ variants, the predo-
minant brain and spinal cord isoforms, active in target-
ing gephyrin scaffolds to the plasma membrane.
Consistent with CB regulating recruitment of gephyrin
scaffolds to developing inhibitory postsynaptic sites, CB-
deficient mice show loss of postsynaptic gephyrin
and GABAA receptors clusters in the hippocampus
and the amygdala, which is accompanied by impaired
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GABAergic transmission, altered hippocampal synaptic
plasticity and behavioral abnormalities in the mice
[11-13]. The importance of this protein has been further
demonstrated by the identification of mutations in
human CB gene (ARHGEF9, mapped at Xq11.1) in
patients with diverse neurological abnormalities, includ-
ing hyperekplexia, epilepsy, mental retardation, insom-
nia, aggressive behavior and anxiety [2,14,15].
Aside from regulating gephyrin and GABAA receptors
deposition at inhibitory synapses, little is known about
what other functions CB might subserve. In this study,
in an attempt to gain further insight into the role of CB
in neuronal development and function, we sought to
identify novel human CB-interacting partners. Our
results demonstrate that CB is associated with the trans-
lation initiation complex, and suggest that CB, along
with gephyrin, may be involved in the regulation of pro-
tein synthesis at postsynaptic sites.
Materials and methods
Yeast Two-hybrid screening
Yeast two-hybrid screening was conducted using Match-
maker GAL4 two-hybrid system 3 (Clontech, BD Bios-
ciences). Reagents and amino acids required for making
standard dropout (SD) plates for prototroph and colori-
metric screening were obtained from Sigma-Aldrich.
Plasmid constructs
Full-length human CB cDNA (encoding amino acids 1
to 516) and a truncated form lacking the cDNA
sequence for the N-terminal SH3 domain (encoding
amino acids 64 to 516) was cloned downstream of the
GAL4 DNA-binding domain in pGBKT7 vector (plas-
mids pGBKT7-CB and pGBKT7-CBSH3-, expressing the
bait proteins GAL4BD-CB and GAL4BD-CBSH3- respec-
tively). Full-length human gephyrin cDNA (enconding
amino acids 1 to 769) was cloned downstream of the
GAL4 activation domain vector pGADT7 (plasmid
pGADT7-gephyrin, expressing the prey protein
GAL4AD-gephyrin).
Testing the bait protein
After construction of the bait plasmids, the yeast strain
AH109 was transformed and evaluated for bait proteins
expression, transcription activation in the absence of a
binding partner and effect on mating efficiency. These
initial control studies suggested that human CB would
be effective bait in the screen.
Yeast mating and screening
A human fetal brain cDNA library in the GAL4 activa-
tion domain vector pACT2 pretransformed into the
yeast strain Y187 was screened in a yeast two-hybrid
assay through large scale mating to AH109 expressing
GAL4BD-CB following the manufacturer’s instructions.
Mating efficiency was determined to be within the
acceptable limits according to the manufacturer’s
protocol. Diploid cells were screened for growth on SD
agar plates lacking leucine, tryptophan, adenine, histi-
dine (to verify the expression of ADE2 and HIS3 repor-
ter genes) and containing X-a-Gal (to verify the
expression of LacZ reporter gene) and 5 mM 3-amino-
1,2,4 triazole (3-AT) for 7 days at 30°C. Positive colonies
were subjected to a new phenotype test for segregation
of independent clones, preventing the presence of two
or more plasmids derived from the library in a single
clone. Thus, positive colonies were streaked on SD/-
Leu/-Trp/-Ade/-His/X-a-Gal/5 mM 3-AT plates and
segregation was confirmed by the observation of white
and blue colonies. Positive blue clones were further eval-
uated for beta-GAL expression by colony-lift filter assay,
according to the manufacturer’s instructions. Total plas-
mids were extracted from these putative positive inter-
action yeast colonies and transformed into Escherichia
coli DH5a competent cells (Invitrogen) followed by iso-
lation of the pACT2-cDNA plasmids. To retest the posi-
tive interaction, individual clones of pACT2-cDNA were
cotransformed with pGBKT7-CB or pGBKT7-CBSH3-
into AH109 and analysed aforementioned. The putative
positives were also tested against plasmid pGBKT7
alone to discard false positives. After confirmation of
interaction, pACT2-cDNAs were sequenced and ana-
lysed by comparison to GenBank sequences.
Antibodies
Mouse monoclonal anti-Myc antibody was obtained from
Clontech. Mouse monoclonal anti-Flag M2 antibody was
obtained from Sigma. Mouse monoclonal anti-Collybistin
antibody was obtained from BD Transduction Labora-
tories. Goat polyclonal anti-Gephyrin (R-20), anti-eIF3B
(N-20), and anti-BMP1 (A-20) antibodies were purchased
from Santa Cruz Biotechnology. Rabbit polyclonal anti-
eIF3H and anti-Sox2 antibodies were purchased from
Cell Signaling.
Mammalian expression constructs
Full-length human CB and gephyrin cDNAs were gener-
ated by PCR and subcloned into a pcDNA3.1 vector
(Invitrogen) that contained sequence encoding the Flag
epitope tag at the 5’ end of the polylinker to allow
expression of N-terminally Flag-tagged proteins. Simi-
larly, full-length human CB, gephyrin and eIF3H
cDNAs were generated by PCR and subcloned into a
pExchange-4 vector (Stratagene), which is an N-terminal
c-Myc tagging vector that allows expression of N-term-
inally Myc-tagged proteins. All constructs were
sequence verified.
Cell culture and transfection
HEK 293T cells were grown in Dulbecco’s modified
Eagles medium supplemented with 10% fetal bovine
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serum (FBS) and 100 U/ml penicillin/streptomycin. The
cultures were maintained at 37°C in a humidified atmo-
sphere of 95% air and 5% CO2. All transfections were
carried out using SuperFect (Qiagen) according to the
manufacturer’s instructions.
Preparation of cell or mouse whole brain lysates
After 48 h of transfection, HEK 293T cells expressing
different combinations of epitope-tagged forms of target
proteins were washed with PBS and lysed in RIPA buf-
fer (1 mL/100 mm plate) containing 50 mM Tris-HCl
(pH 7.4), 150 mM NaCl, 1 mM EDTA, 1% NP-40, 0.1%
SDS, 0.5% deoxycholic acid supplemented with protease
inhibitors. Lysed cells were incubated in ice for 30 min,
centrifuged at 14,000 rpm for 15 min at 4°C, and the
supernatant was saved. Mouse brains were removed,
frozen in liquid nitrogen, lyophilized, and homogenized
in RIPA buffer (1 mL/200 mg). Brain lysates were kept
on ice for 30 mim, and supernatants were collected
after centrifugation at 14,000 rpm for 30 min at 4°C.
Protein concentration was determined with Bio-Rad
protein assay.
Coimmunoprecipitation and immunoblot analysis
For immunoprecipitation from HEK 293T cell lysates,
~1.5 mg of protein were pre-cleared with protein G-
Sepharose (GE Healthcare) and then incubated with anti-
body (4 mg) against the Flag epitope, overnight at 4°C on
a rotating platform. For immunoprecipitation from
mouse whole brain lysates, ~10 mg of proteins were pre-
cleared with protein G-Sepharose and then incubated in
the presence of antibodies (4 mg) against the eIF3H or
eIF3B proteins, or irrelevant isotype-matched antibodies
as negative controls, overnight with rotation at 4°C. Sub-
sequently, all lysates were incubated with 50 mL protein
G-Sepharose for 3-4 h at 4°C on a rotating platform.
After centrifugation, beads were washed 3 times with
RIPA buffer and once with 50 mM Tris-HCL pH 8.0.
The bead-bound proteins were eluted with SDS sample
buffer, resolved by SDS-PAGE, and analyzed by Western
blotting. Expression of epitope-tagged recombinant pro-
teins or endogenous proteins from whole-brain extracts
was also analysed by loading equivalent amounts of
lysates into the gel. For immunodetection, blots were
incubated with the primary antibody solutions, followed
by HRP-conjugated secondary antibodies. Bound HRP
was detected using the enhanced chemiluminescence
(ECL) system (Amersham Biosciences).
Results
Identification of eIF3H as a collybistin binding partner
To identify novel CB-interacting partners, we performed
a yeast-two-hybrid screen of a human fetal brain cDNA
library using the full-length human CB as bait. From
~2.7 × 106 clones screened, 8 positive clones were iso-
lated using the most stringent reporter selection. To ret-
est protein-protein interaction in yeast, library plasmids
were rescued and cotransformed into the AH109 yeast
strain with either the pGBKT7-CB plasmid (expressing
the bait protein GAL4BD-CB) or an empty pGBKT7
vector (negative control). Four of these clones were
judged to be true-positives and two of them contained
the full-length coding sequence of p40 subunit of the
eukaryotic translation initiation factor 3 (eIF3H). Yeast-
two-hybrid assay using the human CB lacking the SH3
domain (bait protein GAL4BD-CBSH3-) showed that this
truncated form of CB can also interact with eIF3H, indi-
cating that this domain is not required to mediate the
interaction with eIF3H (Figure 1).
Collybistin and gephyrin associate with eIF3H in
mammalian cells
To investigate whether CB and eIF3H associate in a
mammalian cell context, coimmunoprecipitation assays
were carried out.
Initially, HEK 293T cells were cotransfected with
expression plasmids encoding Myc-tagged CB and Flag-
tagged gephyrin or Flag-tagged CB and Myc-tagged
gephyrin as positive control for protein interactions. Cell
lysates were immunoprecipitated with anti-Flag anti-
body, followed by immunoblot analysis with anti-Myc
antibody. We observed, as expected, that Myc-CB (Fig-
ure 2A, top left panel) and Myc-gephyrin (Figure 2A,
top right panel) were present in the immunocomplex
precipitated with anti-Flag antibody.
pGADT7-eIF3H
pGBKT7-CB +
+
-
pGADT7-gephyrin
pGBKT7-CBSH3-
-
+
+
-
-
+
+
-
-
+
+
-
-+
-
-
-
SD/ Leu/ Trp/ Ade/ His/X α Gal/5mM 3 AT
-pGBKT7-φ - - -+
- - - - - -  -
Figure 1 Yeast two-hybrid assay . Yeast strain AH109
cotransformed with pGBKT7-CB or pGBKT7-CBSH3- bait plasmids and
pGADT7-eIF3H prey plasmid grew on SD/-Leu/-Trp/-Ade/-His/X-a-
Gal/5 mM 3AT plates, whereas a control transformant, with a
pGBKT7 empty vector and pGADT7-eIF3H, did not. As CB-bait
specific positive interaction control, yeast strain AH109 was
cotransformed with pGBKT7-CB or pGBKT7-CBSH3- and pGADT7-
gephyrin vectors. Results shown are representative of at least three
independent experiments.
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Next, HEK 293T cells were cotransfected with expres-
sion plasmids encoding Flag-CB and Myc-tagged eIF3H.
Anti-Flag antibody was used to immunoprecipitate Flag-
CB from cell lysates, and coimmunoprecipitated Myc-
eIF3H was detected by immunoblotting with anti-Myc
antibody (Figure 2B, top left panel). These results
demonstrate that CB interacts with eIF3H in mamma-
lian cells.
We then examined the possibility that gephyrin may
also interact with eIF3H. Flag-gephyrin and Myc-eIF3H
were transiently expressed in HEK 293T cells. Following
immunoprecipitation with anti-Flag antibody, an immu-
noblot of this material with anti-Myc antibody showed
coimmunoprecipitation of Flag-gephyrin and Myc-eIF3H
(Figure 2B, top middle panel). These results demonstrate
that gephyrin also interacts with eIF3H in mammalian
cells. Whereas we cannot rule out the possibility that
gephyrin may mediate the CB-eIF3H interaction in HEK
293T, which express endogenous gephyrin, CB seems
not to be required for gephyrin-eIF3H association, since
detectable levels of endogenous CB was not observed in
HEK 293T cells (data not shown).
Finally, complex formation of CB, gephyrin and eIF3H
was investigated. Myc-CB, Myc-eIF3H and Flag-
gephyrin were transiently expressed in HEK 293T cells
and the immunoprecipitation was done using the anti-
Flag antibody. After immunoblotting with anti-Myc anti-
body, we observed that Myc-CB and Myc-eIF3H could
be coimmunoprecipitated with Flag-gephyrin (Figure 2B,
top right panel). Although we cannot rule out the possi-
bility that these results are due to the formation of two
independent protein complexes, CB-gephyrin and
gephyrin-eIF3H, they suggest that these interactions are
not mutually exclusive (as both could potentially form
at the same time), and raise the possibility that CB,
gephyrin and eIF3H can form a trimeric protein com-
plex in mammalian cells.
Collybistin and gephyrin associate with eIF3 in the brain
We next examined whether CB and gephyrin associate
with eIF3H in mouse brain. Immunoblot analysis of
adult mouse whole brain lysates showed expression of
endogenous CB, gephyrin and several subunits of the
eIF3 complex, including eIF3H and eIF3B (also known
as eIF3-p116) (data not shown). Since the antibodies
available against CB and gephyrin were not suitable for
immunoprecipitation, we used an eIF3H-specific anti-
body for immunoprecipitation followed by immunoblot-
ting with anti-CB or anti-gephyrin antibodies. We
observed co-immunoprecipitation of endogenous CB as
well as gephyrin with eIF3H from mouse whole brain
homogenates (Figure 3A, top left panel and bottom
left panel respectively). No coimmunoprecipitation of
Myc-gephyrin
A
B
Flag-CB + -
Flag-CB
Flag-gephyrin
Myc-CB +
+
-
-
IgG-Hc
Myc-gephyrin
Myc-CB
-
-
+
+
IP: anti-Flag
Blot: anti-Myc
KDa
75
50
Cell lysates:
Blot: anti-Myc
Flag-gephyrin
Myc-CB
Blot: anti-Flag
75
75
-
Flag-CB
Myc-gephyrin
Flag-gephyrin
Myc-eIF3H +
-
+
+
+
+
+
KDa
50
35
Myc-CB
Myc-eIF3H
IgG-Hc
Flag-CB or Myc-CB
Myc-eIF3H
Flag-gephyrin
IP: anti-Flag
Blot: anti-Myc
KDa
75
50
Blot: anti-Myc + 
anti-Flag
Cell lysates:
Myc-CB - -
Figure 2 CB, gephyrin and eIF3H interaction in a mammalian
cell context. 293T cells were cotransfected with plasmids
enconding the indicated combinations of the epitope-tagged
proteins: (A) Myc-CB (~62 kDa) and Flag-gephyrin (~95 kDa), Flag-
CB (~62 kDa) and Myc-gephyrin (~95 kDa); (B) Flag-CB and Myc-
eIF3H (~40 kDa), Myc-eIF3H and Flag-gephyrin, Myc-CB and Myc-
eIF3H and Flag-gephyrin. As negative controls 293T cells were
cotransfected with a plasmid encoding the Flag-tag alone along
with plasmids encoding the Myc-tagged proteins (data not shown).
Immunoprecipitations were carried out using anti-Flag antibody and
immunoblots were performed using anti-Myc antibody (top panels).
Coimmunoprecipitations of CB-gephyrin (A, top panels), CB-eIF3H
(B, top left panel), gephyrin-eIF3H (B, top middle panel), CB-
gephyrin-eIF3H (B, top right panel) were observed. In analyzing
negative controls, no detectable protein coimmunoprecipitation
was accomplished (data not shown). Expression levels of the
ectopic expressed proteins were confirmed by direct
immunoblotting of equivalent amounts of the lysates using anti-
Flag and/or anti-Myc antibodies as shown in the lower panels. All
results shown are representative of two-four independent
experiments. IP = antibody used for immunoprecipitation; Blot =
antibody used for immunoblot analysis; IgG-Hc = immunoglobulin
heavy chain (~55 kDa).
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collybistin and gephyrin were detected using an isotype-
matched antibody (Figure 3A, top middle and bottom
middle panels respectively). The same results were
obtained when we used an antibody against eIF3B for
immunoprecipitation (Figure 3B). These results indicate
that CB and gephyrin associate with the eIF3 complex
in the brain.
Discussion
Here, we used the yeast two-hybrid (YTH) approach to
search for proteins that associate with human CB and
identified eIF3H as a potential interaction partner. Also,
through YTH assay, we showed that the SH3 domain of
CB is not required for interaction with eIF3H. Interac-
tion of CB and eIF3H was further substantiated by
coimmunoprecipitation of transiently expressed proteins
in 293T cells. In addition, we showed that gephyrin also
interacts with eIF3H in 293T cells and that CB, gephyrin
and eIF3H seem to assemble into a trimeric protein
complex. Finally, in mouse brain tissue, we could
demonstrate the interaction of endogenous CB and
gephyrin with the eIF3 complex. In conclusion, we
showed by independent approaches that CB and
gephyrin bind to eIF3.
Translation initiation in eukaryotes requires the parti-
cipation of several eukaryotic initiation factors (eIFs),
and the eIF3 is the largest and most complex of the
eIFs, consisting of 13 subunits (designated eIF3A to eIF3
M in order of decreasing size) in mammalian cells
[16,17]. eIF3 plays a central role in translation initiation
and its regulation, including formation of the 43 S prei-
nitiation complex (consisting of the eIF2-GTP-Met-
tRNA ternary complex, eIF3, eIF1, eIF1A, eIF5 and the
40 S ribosomal subunit), binding of the 43 S preinitia-
tion complex to the 5’-m7G-capped mRNA, and reach-
ing the AUG codon [16,18]. In addition, recently eIF3
was also shown to provide focal points for translational
control of gene expression in response to stimuli (such
as nutrients, energy sufficiency, hormones and mitogenic
agents) through association with mTOR and S6K1
[19,20], serine/threonine protein kinases which act as
primary regulators of protein synthesis and cell growth.
Thus, the eIF3 complex may act as the general scaffold-
ing platform, bringing all components of the process
into close proximity.
Although the roles played by CB and gephyrin in this
scenario have yet to be defined, our molecular data on
the physical interaction of CB and gephyrin with eIF3
suggest that these proteins may participate in translation
initiation. It is particularly important to note that
gephyrin was previously shown to associate with mTOR,
and this interaction appears to be necessary for down-
stream signaling of mTOR [21]. In light of these find-
ings, it is tempting to speculate that gephyrin acts,
A
CB
IgG-Hc
IP
Brain
lysate Blot
Gephyrin
IgG-Hc
eIF3H Sox2
KDa
75
75
B
IP
Brain
lysate Blot
eIF3B BMP1
Gephyrin
IgG-Hc
CB
IgG-Hc
KDa
75
75
Figure 3 Interaction of CB, gephyrin and eIF3 in the brain.
Adult mouse whole brain lysates were immunoprecipitated using
(A) anti-eIF3H or (B) anti-eIF3B antibodies and endogenous CB (~62
kDa) and gephyrin (~95 kDa) were detected in immunoprecipitated
samples using anti-CB and anti-gephyrin specific antibodies
respectively. As negative controls, corresponding isotype-matched
immunoglobulin G antibodies (including rabbit anti-Sox2 and goat
anti-BMP1 antibodies) were used for immunoprecipitaion, and no
coimmunoprecipitation of CB and gephyrin was observed. All results
shown represent one of at least three independent experiments.
Although a faint band corresponding to coimmunoprecipitated CB
was detected using anti-eIF3B antibody for immunoprecipitation (B,
top left panel), it is worth pointing that the same weak but specific
CB band was observed in all the experiments, which suggest that
CB also interacts with the eIF3 complex. IP = antibody used for
immunoprecipitation; Blot = antibody used for immunoblot analysis;
IgG-Hc = immunoglobulin heavy chain (~55 kDa).
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indeed, as a scaffold protein bridging together CB, eIF3
and mTOR, and that CB, maybe through its GEF activ-
ity, is the protein responsible for activation of mTOR
signaling. One possibility is that CB may promote gua-
nine nucleotide exchange on Rheb, a Ras-related
GTPase that when linked to GTP activates mTOR’s
enzyme activity [22,23]. It is interesting to note that the
S. cerevisiae protein Cdc24p, which shows both func-
tional and sequence homology (26% identity) with
human CB and also acts as GEF for Cdc42p, interacts
with the yeast TOR protein complexes [24]. Alterna-
tively, CB may have a direct effect on eIF3 assembly
and/or function, independent on mTOR, or CB function
may rely on translocation of the translation machinery
to synaptic sites. We are currently performing follow-up
experiments to address these important issues.
It has been well established that protein synthesis
can occur in specific subcellular regions of a neuron in
response to extracellular signal, and colocalization of
the translational machinery together with cell surface
receptors and signaling molecules near or at synapses
may play important role in synaptic function and plas-
ticity [25-28]. Importantly, mTOR pathways also have
been implicated in local translation and synaptic plasti-
city in dendrite [29]. Results from our study thus pro-
vide initial support for the involvement of CB and
gephyrin in the control of protein synthesis at inhibi-
tory synapses, and also provide a framework for further
investigation into the molecular mechanisms involved
in local synaptic translation and in the pathophysiology
of diseases associated with mutations in these proteins.
Moreover, our results, together with results from pre-
vious studies, link CB and gephyrin to biological path-
ways associated with autism, which make these
proteins also plausible candidates for autism
susceptibility.
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